15 participants
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2025-03-10
- Completion:
- 2026-12-01
Conditions
- Autoimmune Lymphoproliferative Syndrome
Interventions
- DRUG
No Results Yet